Multiresistant CTX-M-15 ESBL-producing Escherichia coli in southern Sweden: Description of an outbreak

References

• Livermore D. Defining an extended-spectrum beta-lactamase. CMI 2008; 14(Suppl 1)3–10
   Google Scholar
• Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933–51
   PubMed Web of Science ®Google Scholar
• Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 1–14
   PubMed Web of Science ®Google Scholar
• Canton R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, Coque TM. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008; 14(Suppl 1)144–53
   PubMed Web of Science ®Google Scholar
• Naseer U, Natås OB, Haldorsen BC, Bue B, Grundt H, Walsh TR, Sundsfjord A. Nosocomial outbreak of CTX-M-15-producing E. coli in Norway. APMIS 2007; 115: 120–6
   PubMed Web of Science ®Google Scholar
• Nyberg, SD, Osterblad, M, Hakanen, AJ, Huovinen, P, Jalava, J, The Finnish Study Group for Antimicrobial Resistance. Detection and molecular genetics of extended-spectrum beta-lactamases among cefuroxime-resistant Escherichia coli and Klebsiella spp. isolates from Finland, 2002–2004. Scand J Infect Dis 2007;39:417–24.
   PubMed Web of Science ®Google Scholar
• Jensen LB, Hasman H, Agerso Y, Emborg HD, Aarestrup FM. First description of an oxyimino-cephalosporin-resistant, ESBL-carrying Escherichia coli isolated from meat sold in Denmark. J Antimicrob Chemother 2006; 57: 793–4
   PubMed Web of Science ®Google Scholar
• EARSS Management Team, members of the Advisory Group, and national representatives of EARSS. Annual Report 2006. Bilthoven, the Netherlands, October, 2007.
   Google Scholar
• SWEDRES. 2007. A report on antimicrobial use and resistance. J Struwe, Olsson-Liljequist, B.. Strama and Swedish Institute for Infectious Disease Control.
   Google Scholar
• Fang H, Lundberg C, Olsson-Liljequist B, Hedin G, Lindbäck E, Rosenberg Å, Struwe J. Molecular epidemiological analysis of Escherichia coli isolates producing extended-spectrum beta-lactamases for identification of nosocomial outbreaks in Stockholm, Sweden. J Clin Microbiol 2004; 42: 5917–20
   PubMed Web of Science ®Google Scholar
• Lytsy B, Sandegren L, Tano E, Torell E, Andersson D, Melhus Å. The first major extended-spectrum beta-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae-producing CTX-M-15. APMIS 2008; 116: 302–8
   PubMed Web of Science ®Google Scholar
• PR Murray, Manual of Clinical Microbiology, 9th edn. Washington DC: ASM Press; 2007.
   Google Scholar
• The Swedish Reference Group for Antibiotics (SRGA) and its subcommittee on methodology (SRGA-M), http://www.srga.org.
   Google Scholar
• Melhus Å. Juhlin's medium, a selective and differential medium for Gram-negative rods. Med Microbiol Lett 1996; 5: 74–81
   Google Scholar
• Matthew M, Harris AM, Marshall MJ, Ross GW. The use of analytical isoelectrical focusing for detection and identification of beta-lactamases. J Gen Microbiol 2005; 88: 169–78
   Google Scholar
• Steward CD, Rasheed JK, Hubert SK, Biddle JW, Raney PM, Anderson GJ, et al. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum β -lactamase detection methods. J Clin Microbiol 2001; 39: 2864–72
   PubMed Web of Science ®Google Scholar
• Rasheed JK, Jay C, Metchock B, Berkowitz F, Weigel L, Crellin J, et al. Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteraemia. Antimicrob Agents Chemother 1997; 41: 647–53
   PubMed Web of Science ®Google Scholar
• Boyd DA, Tyler S, Christianson S, McGeer A, Muller MP, Willey BM, et al. Complete nucleotide sequence of a 92-kb plasmid harbouring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term care facilities in Toronto, Canada. Antimicrob Agents Chemother 2004; 48: 3758–64
   PubMed Web of Science ®Google Scholar
• Maslow JN, Slutsky AM, Arbeit RD. Application of pulsed-field gel electrophoresis to molecular epidemiology. Diagnostic molecular microbiology: principles and applications, DH Persing, TF Smith, FC Tenover, TJ White. ASM Press, Washington, D.C. 1993; 563–72
   Google Scholar
• Rodriguez-Bano J, Ngugro MD. Extended-spectrum beta-lactamases in ambulatory care: a clinical perspective. Clin Microbiol Infect 2008; 14(Suppl 1)104–10
   PubMed Web of Science ®Google Scholar
• Rossolini GM, D'Andrea MM, Mugnaioli C. The spread of CTX-M-type extended-spectrum beta-lactamases. Clin Microbiol Infect 2008; 14(Suppl 1)33–41
   PubMed Web of Science ®Google Scholar
• Nicolas-Chanoine M-H, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Canica MM, et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 61: 273–81
   PubMed Web of Science ®Google Scholar
• Apisarnthanarak A, Bailey TC, Fraser VJ. Duration of stool colonization in patients infected with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis 2008; 46: 1322–3
   PubMed Web of Science ®Google Scholar
• Erntell, M, Skoog, G, Cars, O, Elowson, S, Hanberger, H, Jorup, C, , et al Changes in patterns of antimicrobial use in Swedish hospitals, 2003–2006, following the introduction of large-scale nationwide point prevalence studies. Oral presentation O404, 18^th ECCMID. 2008, Barcelona, Spain.
   Google Scholar
• Tärnberg, M, Östholm Barkhed, Å, Hanberger, H, Johansson, AV, Monstein, HJ, Nilsson, M, et al. Prevalence of faecal carriage of ESBL-producing Enterobacteriaceae in patients with severe abdominal infections. Poster presentation P630, 18^th ECCMID. 2008, Barcelona, Spain.
   Google Scholar